Shelby C. Wilkinson

Shelby C. Wilkinson has a wealth of experience in the business and healthcare industries. Starting in 2012, they held a Research Laboratory Technician role at Dean Mcgee Eye Institute. In 2015, they were an Innovation & Venture Capital Research Fellowship at Mack Institute for Innovation Management. In 2016, they were a Protein Sciences Intern at Vertex Pharmaceuticals. In 2017, they were an Investment Banking Summer Analyst at Centerview Partners and a Licensing Intern at Children's Hospital of Philadelphia. In 2018, they held roles as a Consultant for New Product Planning & Business Development at Cabaletta Bio and an Analyst for Commercial Insights & Corporate Strategy at Tessa Therapeutics Pte Ltd.

Shelby C. Wilkinson attended the University of Pennsylvania from 2014 to 2018, earning a B.A. in Biology with a Concentration in Molecular and Cell Biology. During the same time period, they also attended The Wharton School and earned a Bachelor of Sciences (BS) in Economics with a Concentration in Finance. Shelby C. then went on to attend Harvard Medical School from 2020 to 2024, where they earned a Doctor of Medicine (M.D.).